A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
Clinical trial NCT04104672 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04104672
- Sponsor
- Arcus Biosciences, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2027-05-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.